After ‘nightmare’ of pain, woman with MS questions why drug shortages aren’t prevented

Lorely Gaunt and Melanie Gaunt

Melanie Gaunt says the synthetic cannabinoid nabilone was “a godsend.” Then the company that makes it ran short, a situation one pharmacist says may be tied to the rising demand for alternatives to opioids.

Post Author: martin

Martin is an enthusiastic programmer, a webdeveloper and a young entrepreneur. He is intereted into computers for a long time. In the age of 10 he has programmed his first website and since then he has been working on web technologies until now. He is the Founder and Editor-in-Chief of BriefNews.eu and PCHealthBoost.info Online Magazines. His colleagues appreciate him as a passionate workhorse, a fan of new technologies, an eternal optimist and a dreamer, but especially the soul of the team for whom he can do anything in the world.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.